Table 2.
Oxidized phospholipid-apoprotein cross-link adducts identified in human HDL and in human plasma exposed to MPO−H2O2−NO2− system
HDL (0.5 mg/ml) was incubated with MPO (30 nm), NaNO2 (500 μm), H2O2 (added to 100 μm/h) and DTPA (200 μm) at 37 °C. After 2 h incubation samples were subjected to NaBH4 reduction, tryptic digestion, peptide enrichment, and LC-MS/MS analysis. Experiments using human plasma were carried out similarly. The MS/MS spectra obtained were searched against a protein sequence database containing major and minor apoproteins of human HDL using Massmatrix search engine to identify oxPL-peptide cross-link adducts as described under “Experimental procedures.”
| Cross-linked apoproteins | Cross-linked residues (oxPL type) | Peptides cross-linked by oxPLs | Human HDL | Human plasma | |
|---|---|---|---|---|---|
| ApoA-I–apoA-I | ApoA-I H135–apoA-I K107 (KODA-PL) | LH$ELQEKLSPLGEEMRa | K$WQEEMELYR | √ | - |
| ApoA-I H135–apoA-I K107 (KOOA-PL) | VEPLRAELQEGARQKLH$ELQEK | K$WQEEMELYR | - | √ | |
| ApoA-I H162–apoA-I K94 (KOHA-PL) | DLEEVK$AKVQPYLDDFQK | TH$LAPYSDELRQR | √ | - | |
| ApoA-I H162–apoA-I K118 (KOOA-PL) | TH$LAPYSDELR | QK$VEPLR | √ | - | |
| ApoA-I H199–apoA-I K195 (KODA-PL) | LAEYHAK$ATEH$LSTLSEK | √ | - | ||
| ApoA-I–apoA-II | ApoA-I H135–apoA-II K46 (KOOA-PL) | LH$ELQEK | SK$EQLTPLIK | √ | - |
| ApoA-I H155–apoA-II K28 (KOHA-PL) | AH$VDALR | DLMEK$VK | - | √ | |
| ApoA-I H155–apoA-II K30 (KOHA-PL) | DLMEKVK$SPELQAEAKSYFEK | DRARAH$VDALR | √ | - | |
| ApoA-I H155–apoA-II K46 (KOOA-PL) | AH$VDALR | SK$EQLTPLIKK | √ | - | |
a H$ and K$ represent histidine and lysine residues cross-linked by oxPLs.